pubmed-article:19855285 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:19855285 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:19855285 | lifeskim:mentions | umls-concept:C0035648 | lld:lifeskim |
pubmed-article:19855285 | lifeskim:mentions | umls-concept:C0008976 | lld:lifeskim |
pubmed-article:19855285 | lifeskim:mentions | umls-concept:C0040034 | lld:lifeskim |
pubmed-article:19855285 | lifeskim:mentions | umls-concept:C0205267 | lld:lifeskim |
pubmed-article:19855285 | lifeskim:mentions | umls-concept:C0021149 | lld:lifeskim |
pubmed-article:19855285 | lifeskim:mentions | umls-concept:C1963724 | lld:lifeskim |
pubmed-article:19855285 | pubmed:issue | 5 | lld:pubmed |
pubmed-article:19855285 | pubmed:dateCreated | 2009-11-25 | lld:pubmed |
pubmed-article:19855285 | pubmed:abstractText | Incidence and risk factors for thrombocytopenia in patients discontinuing highly active antiretroviral therapy (HAART) have not been fully investigated. | lld:pubmed |
pubmed-article:19855285 | pubmed:language | eng | lld:pubmed |
pubmed-article:19855285 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19855285 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:19855285 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19855285 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19855285 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:19855285 | pubmed:month | Dec | lld:pubmed |
pubmed-article:19855285 | pubmed:issn | 1944-7884 | lld:pubmed |
pubmed-article:19855285 | pubmed:author | pubmed-author:KatlamaChrist... | lld:pubmed |
pubmed-article:19855285 | pubmed:author | pubmed-author:BierlingPhili... | lld:pubmed |
pubmed-article:19855285 | pubmed:author | pubmed-author:MorlatPhilipp... | lld:pubmed |
pubmed-article:19855285 | pubmed:author | pubmed-author:MolinaJean-Mi... | lld:pubmed |
pubmed-article:19855285 | pubmed:author | pubmed-author:MeiffredyVinc... | lld:pubmed |
pubmed-article:19855285 | pubmed:author | pubmed-author:AboulkerJean-... | lld:pubmed |
pubmed-article:19855285 | pubmed:author | pubmed-author:VittecoqDanie... | lld:pubmed |
pubmed-article:19855285 | pubmed:author | pubmed-author:MarchouBrunoB | lld:pubmed |
pubmed-article:19855285 | pubmed:author | pubmed-author:BouldouyreMar... | lld:pubmed |
pubmed-article:19855285 | pubmed:author | pubmed-author:CharreauIsabe... | lld:pubmed |
pubmed-article:19855285 | pubmed:author | pubmed-author:TangrePhilipp... | lld:pubmed |
pubmed-article:19855285 | pubmed:author | pubmed-author:ANRS 106... | lld:pubmed |
pubmed-article:19855285 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:19855285 | pubmed:volume | 52 | lld:pubmed |
pubmed-article:19855285 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:19855285 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:19855285 | pubmed:pagination | 531-7 | lld:pubmed |
pubmed-article:19855285 | pubmed:meshHeading | pubmed-meshheading:19855285... | lld:pubmed |
pubmed-article:19855285 | pubmed:meshHeading | pubmed-meshheading:19855285... | lld:pubmed |
pubmed-article:19855285 | pubmed:meshHeading | pubmed-meshheading:19855285... | lld:pubmed |
pubmed-article:19855285 | pubmed:meshHeading | pubmed-meshheading:19855285... | lld:pubmed |
pubmed-article:19855285 | pubmed:meshHeading | pubmed-meshheading:19855285... | lld:pubmed |
pubmed-article:19855285 | pubmed:meshHeading | pubmed-meshheading:19855285... | lld:pubmed |
pubmed-article:19855285 | pubmed:meshHeading | pubmed-meshheading:19855285... | lld:pubmed |
pubmed-article:19855285 | pubmed:meshHeading | pubmed-meshheading:19855285... | lld:pubmed |
pubmed-article:19855285 | pubmed:meshHeading | pubmed-meshheading:19855285... | lld:pubmed |
pubmed-article:19855285 | pubmed:meshHeading | pubmed-meshheading:19855285... | lld:pubmed |
pubmed-article:19855285 | pubmed:meshHeading | pubmed-meshheading:19855285... | lld:pubmed |
pubmed-article:19855285 | pubmed:meshHeading | pubmed-meshheading:19855285... | lld:pubmed |
pubmed-article:19855285 | pubmed:meshHeading | pubmed-meshheading:19855285... | lld:pubmed |
pubmed-article:19855285 | pubmed:meshHeading | pubmed-meshheading:19855285... | lld:pubmed |
pubmed-article:19855285 | pubmed:meshHeading | pubmed-meshheading:19855285... | lld:pubmed |
pubmed-article:19855285 | pubmed:meshHeading | pubmed-meshheading:19855285... | lld:pubmed |
pubmed-article:19855285 | pubmed:meshHeading | pubmed-meshheading:19855285... | lld:pubmed |
pubmed-article:19855285 | pubmed:meshHeading | pubmed-meshheading:19855285... | lld:pubmed |
pubmed-article:19855285 | pubmed:year | 2009 | lld:pubmed |
pubmed-article:19855285 | pubmed:articleTitle | Incidence and risk factors of thrombocytopenia in patients receiving intermittent antiretroviral therapy: a substudy of the ANRS 106-window trial. | lld:pubmed |
pubmed-article:19855285 | pubmed:affiliation | Department of Infectious Diseases, Hôpital Saint Louis, Assistance Publique Hôpitaux de Paris and University of Paris Diderot-Paris 7, France. marie-anne.bouldouyre@sls.aphp.fr | lld:pubmed |
pubmed-article:19855285 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:19855285 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
pubmed-article:19855285 | pubmed:publicationType | Multicenter Study | lld:pubmed |